TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box
Highlights Chinese patent officially granted by CNIPA on March 17, 2026 Covers core innovations underpinning TempraMed's VIVI Box™ multi-medication storage platform expected to market end of 2026 Strengthens the Company's intellectual property position in one of the world's largest healthcare and consumer markets Supports commercialization strategy and strategic engag
Technology, Biotechnology, Pharmaceuticals, Health
2026-03-24 7:00 AM EDT | TempraMed Technologies Ltd.
Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement
Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament") today announced that, further to the joint press release dated March 10, 2026, the Supreme Court of British Columbia issued an interim order (the "Interim Order") in connection with the previously announced acquisition by Red Light of all the issued and outstandin
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-23 8:15 AM EDT | Red Light Holland Corp.
Rise Nano Optics Announces FDA Class I Device Classification for SPECTRAGUARD(TM) Nano-Optic Lens Technology
Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company") a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that its proprietary, patented SPECTRAGUARD™ nano-optic lens technology is FDA registered and has been classified by the U.S. Food and Drug Administration (FDA) as a Class I exempt medical device. The FDA has accepte
2026-03-23 7:00 AM EDT | Rise Nano Optics Ltd.
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
King of Prussia, Pennsylvania--(Newsfile Corp. - March 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that a podium presentation addressing its lead product candidate, PH-762, will be given in the American Academy of Dermatology's Late-Breaking Research Session S034 on March 28, 2026 in Denver, Col
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-03-23 7:00 AM EDT | Phio Pharmaceuticals Corp.
Defence Therapeutics Announces Warrant Terms Amendment
Montreal, Quebec--(Newsfile Corp. - March 20, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce an amendment to the terms of a total of 800,000 Common Share purchase warrants (the "Warrants") originally issued as part of a private placement closed in 2024. The expiry date will be extended by 12 months and th
Biotechnology, Pharmaceuticals, Health
2026-03-20 6:00 PM EDT | Defence Therapeutics Inc.
Mobile-health Network Solutions Enters Definitive Agreement to Acquire PPG and Kuching Data Center Asset
Singapore, Singapore--(Newsfile Corp. - March 20, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced that, on March 16, 2026, it entered into a definitive Sale and Purchase Agreement ("SPA") to acquire 100% of the issued share capital of PP Grid Sdn. Bhd. ("PPG") from Dato' Ling Tiung Leng (Stanley Ling). Strategic Acquisition Structure This definitive agreement marks the formal
2026-03-20 2:29 PM EDT | Mobile-health Network Solutions
Mobile-health Network Solutions Announces Updated MOU for Acquisition of Malaysian AI Data Centers
Singapore, Singapore--(Newsfile Corp. - March 20, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform today announced the signing of a Strategic Cooperation Memorandum of Understanding ("Strategic MOU") dated March 15, 2026. This agreement updates the framework established on November 19, 2025, for the acquisition of PP GRID SDN. BHD. ("PPG") and its development of high-density artificial intelligence (AI) dat
2026-03-20 2:22 PM EDT | Mobile-health Network Solutions
Edison Issues Report on Picton Property Income (PCTN)
London, United Kingdom--(Newsfile Corp. - March 20, 2026) - Edison issues report on Picton Property Income (LSE: PCTN). In the past week, Picton Property Income (PCTN) has published updates on its asset management and leasing progress, and the ongoing strategic review and formal sale process that was announced in January. The company reports continuing progress with converting its leasing pipeline, particularly in the office sector. The strategic review has attracted interest from a ran
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-03-20 11:59 AM EDT | Edison Group
Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director
Toronto, Ontario--(Newsfile Corp. - March 20, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces the closing of (i) the first tranche of its non-brokered private placement (the "Offering") for gross proceeds of C$859,653.47, led by Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together with the
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-03-20 9:16 AM EDT | Psyched Wellness Ltd.
Functional Brands Inc. Expands International Access for the P2i(TM) by Kirkman(R) Through iHerb
Lake Oswego, Oregon--(Newsfile Corp. - March 20, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that P2i™ Prenatal Multivitamin & Multimineral, is now officially available at
Household / Consumer / Cosmetics, Health
2026-03-20 8:00 AM EDT | Functional Brands Inc.
Delivra Health Brands Launches Dream Water(R) Kids Sleep Gummies in the United States Market
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Dream Water® brand is launching its new Dream Water Kids Sleep Gummies in the US market. Dream Water Kids Sleep Gummies are expected to be available to Company distributors, retailers and e-c
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-03-19 5:30 PM EDT | Delivra Health Brands Inc.
UberDoc Health Technologies Corp. Engages Independent Trading Group as Market Maker
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - UberDoc Health Technologies Corp. (CSE: APPT) ("UberDoc" or "the Company"), an innovative healthcare platform empowering patients to connect with top physicians instantly, announces that it has engaged the services of Independent Trading Group ("ITG") to provide market-making services in accordance with Canadian Securities Exchange ("CSE") policies. ITG will trade shares of the Company on the CS
2026-03-19 4:01 PM EDT | UberDoc
Tersis Technologies Appoints Veteran Patent Strategist Kevin H. Fortin as Vice President of Intellectual Property & Licensing
Brooksville, Florida--(Newsfile Corp. - March 18, 2026) - Tersis Technologies, Inc. (OTCID: TERS) today announced the appointment of Kevin H. Fortin, Esq. as Vice President of Intellectual Property & Licensing, a strategic leadership addition intended to accelerate the Company's patent protection initiatives, strengthen technology defensibility, and develop high-margin intellectual property licensing revenue streams. Mr. Fortin is a registered U.S. Patent Attorney with more than 30
Agriculture, Energy, Alternative Energy, Health
2026-03-18 12:53 PM EDT | Tersis Technologies Inc.
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
Ontario and Arlington, Massachusetts--(Newsfile Corp. - March 18, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Kala Bio, Inc. (NASDAQ: KALA) ("Kala Bio") today announced that Red Li
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-18 8:15 AM EDT | Red Light Holland Corp.
ALST Announces Formal Offer to Acquire 55% Stake in Imperia Calcio
Sunny Isles Beach, Florida--(Newsfile Corp. - March 17, 2026) - ALST (OTCID: ALST) is pleased to formally announce that a strategic offer has been placed to acquire a 55% ownership stake in Imperia Calcio, in collaboration with a team of distinguished investors. This proposal represents a significant step in ALST's continuing commitment to fostering growth in the sports industry and supporting the future development of Imperia Calcio, a club with a rich history and passionate fanbase. T
Healthcare and Hospitals, Retail, Health
2026-03-17 11:31 AM EDT | Allstar Health Brands, Inc.
Adia Med of Winter Park Appoints Amy Dalrymple, APRN, Former Mrs. Florida United States, to Lead Regenerative Aesthetics Division
Winter Park, Florida--(Newsfile Corp. - March 17, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its subsidiary, Adia Med of Winter Park, has appointed Amy Dalrymple, MSN, APRN, FNP-C, a highly experienced aesthetic nurse practitioner and former Mrs. Florida United States, as the leader of its new Regenerative Aesthetics Division.
Healthcare and Hospitals, Health
2026-03-17 9:30 AM EDT | Adia Nutrition Inc.
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 17, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical Synthesis™ platform, today announced that it will report its fourth quarter and full year 2025 financial results after market close on Tuesday, March 31, 2026. The Company will host a conference call and webcast at 4:30 p.m. Eastern Daylight Time to discuss the re
Biotechnology, Pharmaceuticals, Health
2026-03-17 8:30 AM EDT | BioHarvest Sciences Inc.
Rise Nano Optics Appoints Erik Ritchie as Chief Commercial Officer to Lead North American Commercialization Strategy
Vancouver, British Columbia--(Newsfile Corp. - March 17, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced the appointment of Erik Ritchie as Chief Commercial Officer (CCO). Mr. Ritchie will lead Rise's North American commercialization strategy, overseeing go-to-market execution, operations, partnerships, and sales and
2026-03-17 7:00 AM EDT | Rise Nano Optics Ltd.
UBERDOC Health Technologies Corp. Announces Completion of Amalgamation with ROV Investment Partners Corp. and Listing on the CSE
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - UBERDOC Health Technologies Corp. (CSE: SEEM) (OTCQB: ESVNF) ("UBERDOC" or the "Company") is pleased to announce that it has completed its previously announced amalgamation effective March 13, 2026 pursuant to an amalgamation agreement dated May 1, 2025 as amended from time to time (the "Amalgamation Agreement") with ROV Investment Partners Corp. ("ROV") and 1536702 B.C. Ltd. ("Subco
2026-03-16 2:29 PM EDT | UberDoc
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
King of Prussia, Pennsylvania--(Newsfile Corp. - March 16, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silenc
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-03-16 11:30 AM EDT | Phio Pharmaceuticals Corp.